Literature DB >> 19071107

Levo-tetrahydropalmatine attenuates oxycodone-induced conditioned place preference in rats.

Yan-Li Liu1, Ling-Di Yan, Pei-Lan Zhou, Chun-Fu Wu, Ze-Hui Gong.   

Abstract

Levo-tetrahydropalmatine (l-THP) is an alkaloid purified from the Chinese herb corydalis and stephania and is contained in many traditional Chinese herbal preparations. Our previous studies demonstrated the ability of l-THP to inhibit locomotor stimulation and physical dependence induced by oxycodone in mice and rats. The present study was designed to evaluate effects of l-THP on reward of oxycodone using conditioned place preference assay. Oxycodone (0.32-5.0 mg/kg) induced the development of conditioned place preference in rats. Furthermore, oxycodone (2.5 mg/kg) induced the increased phosphorylation of CREB and ERK in nucleus accumbens and hippocampus, but not in prefrontal cortex. l-THP (6.25-18.50 mg/kg) per se was not able to induce conditioned place preference or conditioned place aversion. l-THP co-administered with oxycodone during the conditioning sessions partly abolished the development of oxycodone-induced conditioned place preference in rats. Furthermore, l-THP inhibited the increased phosphorylation of ERK and CREB in nucleus accumbens and hippocampus of rats. All these results suggest that l-THP can inhibit oxycodone-induced psychological dependence by affecting phosphorylation of CREB and ERK in nucleus accumbens and hippocampus of rats. Together, the present data, combined with previous finding, support the potential use of l-THP for treatment of oxycodone addiction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19071107     DOI: 10.1016/j.ejphar.2008.11.031

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

1.  Responses of dopaminergic, serotonergic and noradrenergic networks to acute levo-tetrahydropalmatine administration in naïve rats detected at 9.4 T.

Authors:  Xiping Liu; Zheng Yang; Rupeng Li; Jun Xie; Qian Yin; Alan S Bloom; Shi-Jiang Li
Journal:  Magn Reson Imaging       Date:  2011-11-12       Impact factor: 2.546

Review 2.  l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction.

Authors:  Jia Bei Wang; John R Mantsch
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

3.  Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.

Authors:  Sarah Sushchyk; Zheng-Xiong Xi; Jia Bei Wang
Journal:  J Pharmacol Exp Ther       Date:  2016-02-22       Impact factor: 4.030

4.  Levo-tetrahydropalmatine attenuates cocaine self-administration under a progressive-ratio schedule and cocaine discrimination in rats.

Authors:  John R Mantsch; Samantha Wisniewski; Oliver Vranjkovic; Corey Peters; Amanda Becker; Abbey Valentine; Shi-Jiang Li; David A Baker; Zheng Yang
Journal:  Pharmacol Biochem Behav       Date:  2010-09-09       Impact factor: 3.533

5.  The heritability of oxycodone reward and concomitant phenotypes in a LG/J × SM/J mouse advanced intercross line.

Authors:  Camron D Bryant; Michael A Guido; Loren A Kole; Riyan Cheng
Journal:  Addict Biol       Date:  2012-12-12       Impact factor: 4.280

6.  Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats.

Authors:  Yazmin Figueroa-Guzman; Christopher Mueller; Oliver Vranjkovic; Samantha Wisniewski; Zheng Yang; Shi-Jiang Li; Colin Bohr; Evan N Graf; David A Baker; John R Mantsch
Journal:  Drug Alcohol Depend       Date:  2010-12-31       Impact factor: 4.492

7.  L-tetrahydropalamatine inhibits tumor necrosis factor-α-induced monocyte-endothelial cell adhesion through downregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 involving suppression of nuclear factor-κ B signaling pathway.

Authors:  Bin-rui Yang; Nan Yu; Yan-hui Deng; Pui Man Hoi; Bin Yang; Guang-yu Liu; Wei-hong Cong; Simon Ming-yuen Lee
Journal:  Chin J Integr Med       Date:  2015-03-17       Impact factor: 1.978

8.  Oxycodone decreases anxiety-like behavior in the elevated plus-maze test in male and female rats.

Authors:  Adriaan W Bruijnzeel; Azin Behnood-Rod; Wendi Malphurs; Ranjithkumar Chellian; Robert M Caudle; Marcelo Febo; Barry Setlow; John K Neubert
Journal:  Behav Pharmacol       Date:  2022-08-03       Impact factor: 2.277

9.  Levo-tetrahydropalmatine decreases ethanol drinking and antagonizes dopamine D2 receptor-mediated signaling in the mouse dorsal striatum.

Authors:  Taehyun Kim; David J Hinton; Sandy Johng; Jia Bei Wang; Doo-Sup Choi
Journal:  Behav Brain Res       Date:  2013-01-31       Impact factor: 3.332

Review 10.  Neuronal extracellular signal-regulated kinase (ERK) activity as marker and mediator of alcohol and opioid dependence.

Authors:  Eva R Zamora-Martinez; Scott Edwards
Journal:  Front Integr Neurosci       Date:  2014-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.